PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
-0.49%
Negative cost of revenue growth (cost reduction) can be positive but verify quality impact. Benjamin Graham would examine if cost cuts are sustainable.
0.49%
Gross profit growth below 5% signals weak core performance. Seth Klarman would demand evidence of turnaround potential.
No Data
No Data available this quarter, please select a different quarter.
-36.64%
Negative R&D growth (spending reduction) needs careful analysis. Benjamin Graham would examine impact on competitive position.
-70.64%
Negative G&A growth (overhead reduction) needs verification. Benjamin Graham would examine impact on operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-54.90%
Negative operating expenses growth needs verification. Benjamin Graham would examine sustainability.
-54.90%
Negative total costs growth needs verification. Benjamin Graham would examine sustainability.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative D&A growth needs verification. Benjamin Graham would examine asset reduction strategy.
54.90%
EBITDA growth above 15% demonstrates exceptional operating performance. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
54.90%
Operating income growth above 15% demonstrates exceptional core profitability. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-10.71%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
56.85%
Pre-tax income growth above 15% demonstrates exceptional profitability improvement. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.85%
Net income growth above 15% demonstrates exceptional bottom-line expansion. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
56.86%
EPS growth above 15% demonstrates exceptional shareholder value creation. Warren Buffett would verify sustainability.
56.86%
Diluted EPS growth above 15% demonstrates exceptional value creation despite potential dilution. Warren Buffett would verify sustainability.
-0.00%
Share count reduction needs verification. Benjamin Graham would examine sustainability.
-0.00%
Diluted share reduction needs verification. Benjamin Graham would examine sustainability.